Displaying all 2 publications

Abstract:
Sort:
  1. Arumugasamy N, Sarvananthan R, Rudralingam V, Pillay RP
    Med J Malaysia, 1972 Mar;26(3):168-172.
    PMID: 35158515
    No abstract available.
  2. Rohana J, Boo NY, Chandran V, Sarvananthan R
    Malays J Med Sci, 2011 Oct;18(4):58-62.
    PMID: 22589673 MyJurnal
    Developmental disabilities have been reported in infants with persistent pulmonary hypertension of the newborn (PPHN) treated with inhaled nitric oxide (INO) or intravenous magnesium sulphate (MgSO(4)) and/or extracorporeal membrane oxygenation. This paper reports the rate of developmental disabilities at 2 years of age in a cohort of survivors of PPHN treated with INO, MgSO(4), or both during the neonatal period.
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links